Radical Surgery in Ovarian Cancer
- 24 February 2015
- journal article
- research article
- Published by Springer Nature in Current Oncology Reports
- Vol. 17 (4) , 1-6
Abstract
While there is an ongoing debate regarding the timing of the maximal surgical effort in epithelial ovarian cancer, it is well established that patients with suboptimal tumor debulking derive no benefit from the surgical procedure. The amount of residual disease after cytoreductive surgery has been repeatedly identified as a strong predictor of survival, and accordingly, the surgical effort to achieve the goal of complete gross tumor resection has been constantly evolving. Centers that have adopted the concept of radical surgery in patients with advanced ovarian cancer have reported improvements in their patients’ survival. In addition to the expected improvements in the pharmacologic treatment of this disease, some of the next challenges in the surgical management of ovarian cancer include the preoperative prediction of suboptimal debulking, improving the drug delivery to the tumor, and increasing access to centers of excellence in ovarian cancer regardless of geographical, financial, or other social barriers. This review will discuss an update on the role of surgery in the treatment of primary epithelial ovarian cancer as it has evolved since the emergence of the concept of surgical cytoreduction.Keywords
This publication has 57 references indexed in Scilit:
- Defining the limits of radical cytoreductive surgery for ovarian cancerGynecologic Oncology, 2011
- The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group studyGynecologic Oncology, 2011
- Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancerGynecologic Oncology, 2011
- Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgeryJournal of Gynecologic Oncology, 2011
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian CancerNew England Journal of Medicine, 2010
- Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV DiseaseAnnals of Surgical Oncology, 2010
- Prognostic Impact of Additional Extended Surgical Procedures in Advanced-Stage Primary Ovarian CancerAnnals of Surgical Oncology, 2009
- Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinomaGynecologic Oncology, 2008
- The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concernsGynecologic Oncology, 2006
- What Are the Current Surgical Objectives, Strategies, and Technical Capabilities of Gynecologic Oncologists Treating Advanced Epithelial Ovarian Cancer?Gynecologic Oncology, 2001